Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Primary lung cancer samples of the major histological types were examined for expression of the tumor suppressor gene p53 by immunohistochemistry. Abnormalities in p53 expression were found in 28 of 40 carcinomas, 14 of 17 squamous tumours showing abnormal p53 expression, whereas no expression of p53 was detectable in 7 carcinoid tumours or in 10 normal lung samples. Direct evidence for homozygous expression of mutant p53 mRNA in representative carcinomas was obtained by means of an asymmetric polymerase chain reaction mRNA sequencing strategy, which allowed sequencing without any cloning step. All the mutations were G to T transversions resulting in mis-sense mutations in aminoacids highly conserved in evolution. Mutation of the p53 gene is the most frequently identified genetic change in human lung cancer; these findings suggest that simple immunohistological methods can provide strong evidence of such mutation.


Journal article



Publication Date





675 - 679


Adenocarcinoma, Alleles, Amino Acid Sequence, Autoradiography, Carcinoid Tumor, Carcinoma, Small Cell, Carcinoma, Squamous Cell, Chromosomes, Human, Pair 17, DNA, Neoplasm, Humans, Immunohistochemistry, Lung Neoplasms, Molecular Sequence Data, Mutation, Oligonucleotide Probes, Oncogene Proteins, Phosphoproteins, Polymerase Chain Reaction, RNA, Messenger, Tumor Suppressor Protein p53